Literature DB >> 21228237

Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus.

Joanna Rawling1, Olga Cano, Dominique Garcin, Daniel Kolakofsky, José A Melero.   

Abstract

Cell entry by paramyxoviruses requires fusion between viral and cellular membranes. Paramyxovirus infection also gives rise to the formation of multinuclear, fused cells (syncytia). Both types of fusion are mediated by the viral fusion (F) protein, which requires proteolytic processing at a basic cleavage site in order to be active for fusion. In common with most paramyxoviruses, fusion mediated by Sendai virus F protein (F(SeV)) requires coexpression of the homologous attachment (hemagglutinin-neuraminidase [HN]) protein, which binds to cell surface sialic acid receptors. In contrast, respiratory syncytial virus fusion protein (F(RSV)) is capable of fusing membranes in the absence of the viral attachment (G) protein. Moreover, F(RSV) is unique among paramyxovirus fusion proteins since F(RSV) possesses two multibasic cleavage sites, which are separated by an intervening region of 27 amino acids. We have previously shown that insertion of both F(RSV) cleavage sites in F(SeV) decreases dependency on the HN attachment protein for syncytium formation in transfected cells. We now describe recombinant Sendai viruses (rSeV) that express mutant F proteins containing one or both F(RSV) cleavage sites. All cleavage-site mutant viruses displayed reduced thermostability, with double-cleavage-site mutants exhibiting a hyperfusogenic phenotype in infected cells. Furthermore, insertion of both F(RSV) cleavage sites in F(SeV) reduced dependency on the interaction of HN with sialic acid for infection, thus mimicking the unique ability of RSV to fuse and infect cells in the absence of a separate attachment protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228237      PMCID: PMC3067931          DOI: 10.1128/JVI.02065-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Structural basis of viral invasion: lessons from paramyxovirus F.

Authors:  Robert A Lamb; Theodore S Jardetzky
Journal:  Curr Opin Struct Biol       Date:  2007-09-17       Impact factor: 6.809

2.  A highly sensitive and versatile virus titration assay in the 96-well microplate format.

Authors:  V Borisevich; R Nistler; D Hudman; G Yamshchikov; A Seregin; V Yamshchikov
Journal:  J Virol Methods       Date:  2008-02       Impact factor: 2.014

3.  Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation.

Authors:  C A M de Haan; B J Haijema; P Schellen; P Wichgers Schreur; E te Lintelo; H Vennema; P J M Rottier
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

4.  Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity.

Authors:  Joanna Rawling; Blanca García-Barreno; José A Melero
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

5.  Paramyxovirus fusion: real-time measurement of parainfluenza virus 5 virus-cell fusion.

Authors:  Sarah A Connolly; Robert A Lamb
Journal:  Virology       Date:  2006-08-17       Impact factor: 3.616

6.  Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.

Authors:  Roberta L Crim; Susette A Audet; Steven A Feldman; Howard S Mostowski; Judy A Beeler
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus.

Authors:  Gert Zimmer; Sascha Bossow; Larissa Kolesnikova; Matthias Hinz; Wolfgang J Neubert; Georg Herrler
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.

Authors:  Sandrine Belouzard; Victor C Chu; Gary R Whittaker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

Review 9.  Paramyxovirus membrane fusion: lessons from the F and HN atomic structures.

Authors:  Robert A Lamb; Reay G Paterson; Theodore S Jardetzky
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

10.  Heparin enhances the furin cleavage of HIV-1 gp160 peptides.

Authors:  A Pasquato; M Dettin; A Basak; R Gambaretto; L Tonin; N G Seidah; C Di Bello
Journal:  FEBS Lett       Date:  2007-11-26       Impact factor: 4.124

View more
  15 in total

1.  Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: implications for the virus replication cycle.

Authors:  Vicente Mas; Sander Herfst; Albert D M E Osterhaus; Ron A M Fouchier; José A Melero
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.

Authors:  Fu-Shi Quan; Yonghwan Kim; Sujin Lee; Hong Yi; Sang-Moo Kang; Jadranka Bozja; Martin L Moore; Richard W Compans
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

3.  Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering.

Authors:  Sayantan Bose; Aarohi Zokarkar; Brett D Welch; George P Leser; Theodore S Jardetzky; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

4.  Use of single chain antibody derivatives for targeted drug delivery.

Authors:  Yaghoub Safdari; Vahideh Ahmadzadeh; Masoumeh Khalili; Hossein Zarei Jaliani; Vahid Zarei; Vahid Erfani-Moghadam
Journal:  Mol Med       Date:  2016-04-22       Impact factor: 6.354

Review 5.  Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Authors:  Peter L Collins; José A Melero
Journal:  Virus Res       Date:  2011-09-22       Impact factor: 3.303

Review 6.  Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

Authors:  José A Melero; Vicente Mas; Jason S McLellan
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

7.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Mechanisms of Oncolysis by Paramyxovirus Sendai.

Authors:  O V Matveeva; G V Kochneva; S V Netesov; S B Onikienko; P M Chumakov
Journal:  Acta Naturae       Date:  2015 Apr-Jun       Impact factor: 1.845

Review 9.  Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry.

Authors:  Sayantan Bose; Theodore S Jardetzky; Robert A Lamb
Journal:  Virology       Date:  2015-03-12       Impact factor: 3.616

10.  Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteins.

Authors:  Mickey Pentecost; Ajay A Vashisht; Talia Lester; Tim Voros; Shannon M Beaty; Arnold Park; Yao E Wang; Tatyana E Yun; Alexander N Freiberg; James A Wohlschlegel; Benhur Lee
Journal:  PLoS Pathog       Date:  2015-03-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.